Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $81,660,525    

Indirect Value

   $12,932,114,466      
Total Shares   142,789,105      
Total Value   $13,013,774,992      


Incyte Corp $32,141,876 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $301,214 Neurogene $16,634 Incyte Corp $32,141,876 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $301,214 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
GEVA Synageva BioPharma Corp Director   –       •       •   2014-03-06 4 B $105.75 $39,656,250 I/I 375,000 211,614 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2015-01-07 4 B $94.19 $94,190,000 I/I 1,000,000 9,184,771 2.25 -
INCY Incyte Corp Director   –       •       •   2022-03-10 4 B $71.90 $15,982,720 I/I 218,563 33,419,055 2.25 %
INCY Incyte Corp Director   –       •       •   2022-03-09 4 B $71.72 $5,057,550 I/I 70,517 33,217,136 2.25 %
INCY Incyte Corp Director   –       •       •   2022-03-08 4 B $70.68 $7,067,500 I/I 100,000 33,151,989 2.25 %
INCY Incyte Corp Director   –       •       •   2022-02-18 4 B $68.37 $9,096,550 I/I 133,032 32,947,370 2.25 %
INCY Incyte Corp Director   –       •       •   2022-02-22 4 B $68.07 $6,793,536 I/I 99,800 33,039,604 2.25 %
INCY Incyte Corp Director   –       •       •   2022-02-17 4 B $67.40 $19,844,805 I/I 292,972 32,824,461 2.25 %
INCY Incyte Corp Director   –       •       •   2022-02-11 4 B $66.81 $18,475,727 I/I 276,507 32,028,637 2.25 %
INCY Incyte Corp Director   –       •       •   2022-02-10 4 B $66.57 $55,276,314 I/I 819,015 31,752,130 2.25 %
INCY Incyte Corp Director   –       •       •   2022-02-14 4 B $66.02 $33,200,362 I/I 502,852 32,531,489 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-01-25 4 B $58.90 $323,934 I/I 5,500 14,027,837 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-01-31 4 B $57.22 $1,725,084 I/I 30,148 14,364,512 2.25 %
GEVA Synageva BioPharma Corp Director   –       •       •   2013-09-25 4 B $56.63 $59,461,500 I/I 1,050,000 202,583 2.25 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-01-21 4 B $56.57 $7,577,571 I/I 133,414 13,660,140 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-01-24 4 B $56.39 $20,905,291 I/I 362,197 14,022,337 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-02-15 4 B $54.16 $314,099 I/I 5,800 14,369,871 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-02-17 4 B $53.82 $16,367,881 I/I 300,000 14,734,965 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-02-16 4 B $53.73 $5,150,173 I/I 95,165 14,457,794 2.25 %
SGEN Seagen Inc Director   –       •       •   2018-02-01 4 B $52.00 $199,999,956 I/I 3,846,153 44,355,335 2.25 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-01-27 4 B $51.59 $13,573,519 I/I 262,259 14,285,631 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-01-28 4 B $49.70 $2,786,084 I/I 55,258 14,336,671 2.25 %
GEVA Synageva BioPharma Corp Director   –       •       •   2013-01-04 4 B $47.53 $40,862,492 I/I 859,720 176,920 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2012-07-13 4 B $41.20 $36,503,200 I/I 886,000 156,821 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-10-01 4 A $35.89 $10,336 D/D 288 288 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us